Tag Archives: Greater Manchester NHS GMC: Central Manchester University Hospitals NHS Foundation Trust

Eleven Genomics Medicine Centres Planned for England (BBC News / Department of Health / NHS England)

Posted on December 22, 2014 by Dementia and Elderly Care News

Summary The NHS has announced further steps in a genetics project, which will involve 11 Genomics Medicine Centres being created in English hospitals to gather DNA information. The aim is to support the 100,000 Genomes Project in research towards the … Continue reading →

Posted in Acute Hospitals, BBC News, Commissioning, Department of Health, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, Integrated Care, National, NHS, NHS England, Person-Centred Care, Personalisation, Pharmacological Treatments, Quick Insights, Standards, UK, Universal Interest | Tagged 100000 Genome Project: NHS Genomic Medicine Centres, 100000 Genomes Project, Academic Health Science Networks (AHSNs), Advanced Therapies Facility (QEH), Advanced Therapies Facility: Birmingham NIHR / Wellcome Trust Clinical Research Facility (CRF), BBC Health News, BBC Wales News, Birmingham, Birmingham (UK), Birmingham and the Black Country (Dudley Sandwell Walsall and Wolverhampton), Birmingham CDRC, Birmingham Centre for Clinical Haematology, Birmingham Centre for Clinical Trials (BCCT), Birmingham Children’s Hospital, Birmingham City Council, Birmingham City Deal, Birmingham Experimental Arthritis Treatment Centre for Rheumatoid Arthritis (BEAT-RA), Birmingham Health Partners, Birmingham MRC Centre for Immune Regulation, Birmingham NIHR Liver Biomedical Research Unit (BRU), Cambridge, Cambridge University Hospitals NHS Foundation Trust: Genomics Medicines Centre, Cancer Research UK Centre, Cancer Research UK's Stratified Medicine Programme, Cardiff University’s MRC Centre for Neuropsychiatric Genetics and Genomics (MRC CNGG), Central Manchester University Hospitals NHS Foundation Trust: Genomics Medicines Centre, Centre for Clinical Haematology (CCH), Centre for Endocrinology Diabetes and Metabolism (CEDAM), Centre for Obesity Research, Centre for Translational Inflammation (CTIR), Centre for Translational Inflammation Research (QEH), Chronic Disease Resource Centre (CDRC), City of Sandwell and West Birmingham NHS Foundation Trust, Clinical Research Facility (QEH), Decoding Inherited Disorders, Dementia Research, DNA Extraction, Dudley Group of Hospitals, East of England, East of England NHS GMC: Cambridge University Hospitals NHS Foundation Trust, Exeter, Experimental Cancer Medicine Centre (ECMC), Genetic Disorders and Genomics, Genetic Profiling, Genetic Research, Genetic Susceptibility Loci, Genetic Triggers, Genetic Variants, Genetics of Alzheimer's Disease, Genomic Computing, Genomic Medicine, Genomic Medicine Centres, Genomic Medicine Centres (GMCs), Genomic Technologies, Genomics, Genomics England, Genomics in the NHS, Genomics Medicine Centres, Genomics-Based Medicine, Genotyping, George Freeman: Former Life Sciences Minister, Great Ormond Street Hospital NHS Foundation Trust: Genomics Medicines Centre, Greater Manchester, Greater Manchester NHS GMC: Central Manchester University Hospitals NHS Foundation Trust, Guy's and St Thomas' NHS Foundation Trust: Genomics Medicines Centre London, Health Research Bus (HRB), Health Research Trauma Management Healthcare Technology Co-operative (NIHR Trauma Management HTC), Henry Wellcome Building for Nuclear Magnetic Resonance Facility (HWB-NMR), Herceptin, Human Biomaterials Resource Centre (HBRC), Illumina, Imperial College Health Partners NHS GMC: Imperial College Healthcare NHS Trust, Imperial College Healthcare NHS Trust: Genomics Medicines Centre, Inflammation Research Facility (IRF): NIHR / Wellcome Trust Clinical Research Facility, Innovation, Innovation and Improvement, Innovation in Bioinformatics, Innovation in Biotechnology, Innovation in Genetics, Institute for Translational Medicine in Birmingham, Institute of Translational Medicine (ITM), Institute of Translational Medicine: University of Birmingham, Liverpool Women's NHS Foundation Trust: Genomics Medicines Centre, London, Medical Director of NHS England: Professor Sir Bruce Keogh, Microarrays, MRC ARUK Centre for Healthy Ageing, MRC Centre for Neuropsychiatric Genetics and Genomics (MRC CNGG), Multidisciplinary Assessment of Technology Centre for Healthcare (MATCH), National Institute for Health Research (NIHR), National Institute for Health Research Surgical Reconstruction and Microbiology Research Centre (NIHR SRMRC), Networks, Networks and Alliances, Newcastle upon Tyne Hospitals NHS Foundation Trust: Genomics Medicines Centre, Next-Generation Sequencing (NGS), NHS Five Year Forward View, NHS Five Year Forward View (5YFV), NHS Genomic Medicine Centres, NHS Genomic Medicine Centres Prospectus, NHS Genomics Medicine Centres, NHS Workforce, NIHR / Wellcome Trust Birmingham Clinical Research Facility (WTCRF), NIHR Clinical Research Facility, NIHR Collaborations for Leadership in Applied Health Research and Care for Birmingham and the Black Country (NIHR CLAHRC-BBC), NIHR Horizon Scanning Centre, NIHR Translational Research Partnerships (TRPs), North East, North East and North Cumbria NHS GMC: Newcastle upon Tyne Hospitals NHS Foundation Trust, North West Coast NHS GMC: Liverpool Women’s NHS Foundation Trust, Oxford, Oxford NHS GMC: Oxford University Hospitals Foundation Trust, Oxford University Hospitals Foundation Trust: Genomics Medicines Centre, Partnership, Partnership and Collaboration, Partnership Working, Personalised Medicine, Pharmaceutical Industry, Professor David Adams: Dean of Medicine at University of Birmingham Medical School, Professor Mark Caulfield: Chief Scientist at Genomics England, Professor Sir Bruce Keogh, Professor Sue Hill: Chief Scientific Officer for England, QMM: the Student Magazine of the University of Birmingham College of Medical and Dental Sciences, Queen Elizabeth Hospital, Research and Development, Research and Innovation, Research Commitment, Research Consortia, Research Culture, Research Into Aging, Research Networks, Researcher Access to Data, Resources for Researchers, Royal Devon and Exeter NHS Foundation Trust: Genomics Medicines Centre, Shape of Training Report, Shape Of Training Review, Sir John Chisholm: Executive Chair of Genomics England, South London NHS GMC: Guy’s and St Thomas’ NHS Foundation Trust, South West Peninsula, South West Peninsula NHS GMC: Royal Devon and Exeter NHS Foundation Trust, Southampton, Stem Cell Translational Medicine, STXBP1, Targeted Therapies, Translational Research, UK Genomes Project: Genomics England, UK Research and Life Science Sector, University College London Partners NHS GMC: Great Ormond Street Hospital NHS Foundation Trust, University Hospital Southampton NHS Foundation Trust: Genomics Medicines Centre, University Hospitals Birmingham NHS Foundation Trust, University Hospitals Birmingham NHS Foundation Trust: Genomics Medicines Centre, University Hospitals Birmingham: Cancer Clinical Specialties, University of Birmingham, University of Birmingham Medical School, Wales Infants and Children’s Genome Service (Wings), Wellcome Trust Clinical Research Facility, Welsh Government's Genomics for Precision Medicine Strategy (2017), Wessex NHS GMC: University Hospital Southampton NHS Foundation Trust, West Midlands, West Midlands Academic Health Network, West Midlands NHS GMC: University Hospitals Birmingham NHS Foundation Trust, West Midlands RDS: NIHR Research Design Service (RDS), Whole Genome Sequencing | Leave a comment

UK Genomes Project: Genomics England (BBC News / NHS England / HEE / Nature Genetics)

Posted on August 1, 2014 by Dementia and Elderly Care News

Summary A revolution in medicine is in progress at research centres across the UK, based on unlocking the genetic bases of cancer and other diseases. The UK could become a world leader in genetic research, targeted therapies and personalised medicine. … Continue reading →

Posted in BBC News, Department of Health, Health Education England (HEE), In the News, International, National, NHS, NHS England, Personalisation, Quick Insights, UK, Universal Interest | Tagged 100000 Genome Project: NHS Genomic Medicine Centres, 100000 Genomes Project, Aarhus University, Akureyri Hospital (Iceland), Astra Zeneca, BBC Health News, Bioinformatics Research Centre: Aarhus University, Biological Treatments, Biotechnology Companies, Birmingham, Broad Institute / Whitehead Institute (Massachusetts), Bubble-Boy Syndrome (Immune Disorders), Call for Global Moratorium on Clinical Uses of Human Germline Editing, Cambridge, Cambridge University Hospitals NHS Foundation Trust: Genomics Medicines Centre, Cancer Research UK (CRUK), Cas9 (Crispr-Associated Protein 9) Enzyme, Cell and Gene Therapy at Institute of Child Health (ICH), Central Manchester University Hospitals NHS Foundation Trust: Genomics Medicines Centre, Chief Scientific Officer Bulletin, Chief Scientific Officer Bulletin (July 2014), Children's Hospital: Landspitali University Hospital (Reykjavik Iceland), Cleveland Clinic, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), Collaborative Projects, Collaborative Working, Crispr, Crispr-Cas9, CRISPR-Cas9 Genome Editing System, Crisprs (Clustered Regularly Interspaced Short Palindromic Repeats), Cross-Sector Partnerships, David Cameron, deCODE Genetics, deCODE Genetics /Amgen Inc., Decoding Inherited Disorders, Dementia Research, Denmark, Department of Human Genetics: University of Leuven, Department of Internal Medicine: Akureyri Hospital (Iceland), Dilated Cardiomyopathy, Division of Cardiovascular Diseases: Mayo Clinic, DNA Extraction, Dr Francis Collins: Director of National Institutes of Health (USA), Dr Marcy Darnovsky: Center for Genetics and Society (USA), Drugs Targeted at Specific Mutations, Duke University, East Anglian Medical Genetics Service: Cambridge University Hospitals NHS Foundation Trust, East of England, East of England NHS GMC: Cambridge University Hospitals NHS Foundation Trust, Elimination of Porcine Endogenous Retroviruses Using Crispr, Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Erasmus University Medical Center, Ethical Considerations, Ethical Dilemmas, European Bioinformatics Institute, European Bioinformatics Institute: Wellcome Trust Genome Campus, Exeter, Familial Adenomatous Polyposis (FAP), Foetal Stem Cells, Four Ps of Personalised Medicine: Participatory Role for Patients, Four Ps of Personalised Medicine: Precise Diagnoses, Four Ps of Personalised Medicine: Prediction and Prevention of Disease, Four Ps of Personalised Medicine: Targeted and Personalised Interventions, Francis Crick Institute, Fred and Pamela Buffett Cancer Centre (Omaha), Gene Editing in Mice With Duchenne Muscular Dystrophy, Genetic Disorders and Genomics, Genetic Engineering (Pandora's Box), Genetic Modification of Cells: HIV Treatment Strategy, Genetic Profiling, Genetic Research, Genetic Susceptibility Loci, Genetic Triggers, Genetic Variants, Genetics of Alzheimer's Disease, Genome Campus (Wellcome Trust), Genome Sequencing, Genomic Computing, Genomic Medicine, Genomic Medicine Centres, Genomic Medicine Centres (GMCs), Genomics, Genomics Education Programme, Genomics Education Programme (HEE), Genomics England, Genomics England’s Ethics Advisory Committee, Genomics in the NHS, Genomics-Based Medicine, Genotyping, Germline Alterations (Suggested for DMD Huntington's Disease or Cystic Fibrosis), Germline Editing, Germline Gene Editing, Germline Modification, GM Babies, Great Ormond Street Hospital, Great Ormond Street Hospital (GOSH), Great Ormond Street Hospital NHS Foundation Trust: Genomics Medicines Centre, Greater Manchester, Greater Manchester NHS GMC: Central Manchester University Hospitals NHS Foundation Trust, Guy's and St Thomas' NHS Foundation Trust: Genomics Medicines Centre London, Harvard University, Health Education England's Genomics Education Programme, HEE: Health Education England, Herceptin, Hinxton Group, Housekeeping Proteins, Human Embryos Edited (August 2017), Human Genetic Disorders, Human Germline Editing, Human Protein Atlas, Hypertrophic Cardiomyopathy, IBM Watson Health, IBM's Watson Supercomputer, Iceland, Icelandic Medical Center (Laeknasetrid), IL2RG Gene, Illumina, Imperial College Health Partners NHS GMC: Imperial College Healthcare NHS Trust, Imperial College Healthcare NHS Trust: Genomics Medicines Centre, Improved Prevention Based on Underlying Predisposition, In Utero Stem Cell Therapy, Innovation in Biotechnology, Innovation in Genetics, Innovative Genomics Initiative (University of California in Berkeley / University of California in San Francisco), Institute of Child Health (ICH), International Summit on Human Gene Editing, Introducing Genomics in Healthcare (Health Education England Video), Knowledge Networks, Knowledge Translation, Knut & Alice Wallenberg Foundation, Knut and Alice Wallenberg Foundation, Laboratory in Mjodd (RAM) Iceland, Landscape of Mutations in Breast Cancer Whole-Genome Sequences, Landspitali University Hospital (Iceland), Large DNA Banks, Large-Scale Whole-Genome Sequencing, Large-Scale Whole-Genome Sequencing (Iceland), Liverpool Women's NHS Foundation Trust: Genomics Medicines Centre, London, Lund University, Mayo Clinic (Rochester Minnesota), McDonnell Genome Institute: Washington University (St. Louis), Medical Director of NHS England: Professor Sir Bruce Keogh, Medical Research Council (MRC), Microarrays, Moratorium on Heritable Genome Editing, Mutational Signatures, Mutational Signatures in Breast Cancer, Networks, Networks and Alliances, Newcastle upon Tyne Hospitals NHS Foundation Trust: Genomics Medicines Centre, Next-Generation Sequencing (NGS), NHS Genomic Medicine Centres, NHS Genomic Medicine Centres (NHS GMCs), NHS Genomic Medicine Centres Prospectus, NHS Genomics Medicine Centres, NHS Workforce, North East, North East and North Cumbria NHS GMC: Newcastle upon Tyne Hospitals NHS Foundation Trust, North Thames Genomic Medicine Centre, North Thames NHS Genomic Medicine Centre (NHS GMC), North West Coast NHS GMC: Liverpool Women’s NHS Foundation Trust, North West London Healthcare Trust, Nuffield Council on Bioethics, OHSU Knight Cardiovascular Institute, Osteogenesis Imperfecta, Oxford, Oxford NHS GMC: Oxford University Hospitals Foundation Trust, Oxford University Hospitals Foundation Trust: Genomics Medicines Centre, Partnership, Partnership and Collaboration, Partnership Working, Personalised Health Care for Cancer, Personalised Medicine, Personalised Medicine Strategy (NHS England), Personalised Medicine Strategy Board, Personalised Medicine Strategy for the NHS, Personalised Medicine: Improving Outcomes, Peter Grainger: Patient and Public Involvement Representative at St Mark’s Hospital (North West London Healthcare Trust), Pharmaceutical Industry, PHG Foundation, Prof Peter Braude: King's College London, Professor Ian Cumming OBE: HEE Chief Executive, Professor Sir Bruce Keogh, Professor Sue Hill: Chief Scientific Officer for England, Profiling Individual Cancer Genomes (Personalised Medicine), Protein-Coding Cancer Genes, Radboud University, Regional Genetic Laboratories, Research and Development, Research and Innovation, Research Commitment, Research Consortia, Research Culture, Research Into Aging, Research Networks, Researcher Access to Data, Resources for Researchers, Royal Devon and Exeter NHS Foundation Trust: Genomics Medicines Centre, Royal Institute of Technology in Sweden, Sanger Institute, School of Engineering and Natural Sciences, Science Working Group: Cancer, Science Working Group: Infectious Diseases, Science Working Group: Rare Diseases, Small and Medium Enterprises (SMEs), SMEs, Somatic Genetic Basis of Breast Cancer, South London NHS GMC: Guy’s and St Thomas’ NHS Foundation Trust, South West Peninsula, South West Peninsula NHS GMC: Royal Devon and Exeter NHS Foundation Trust, Southampton, St Mark’s Hospital, Sun Yat-sen University in Guangdong (China), Talens, Targeted Drugs, Targeted Therapies, Testes, Thermo Fisher Scientific (Massachusetts), Transformational Elements of NHS Genomic Medicine Centres, UK Genomes Project: Genomics England, UK Research and Life Science Sector, University College London Partners NHS GMC: Great Ormond Street Hospital NHS Foundation Trust, University Hospital Southampton NHS Foundation Trust: Genomics Medicines Centre, University Hospitals Birmingham NHS Foundation Trust: Genomics Medicines Centre, University of Iceland, University of Texas MD Anderson Cancer Center, USA, Viv Parry OBE (Science Broadcaster), Wellcome Trust, Wellcome Trust Sanger Institute, Wessex NHS GMC: University Hospital Southampton NHS Foundation Trust, West Midlands, West Midlands NHS GMC: University Hospitals Birmingham NHS Foundation Trust, Whole Genome Sequencing, Workforce Competencies, Workforce Development, Workforce Training, Xenotransplantation: Avoiding Shortage of Human Donor Organs, Yale Cancer Centre, Zinc fingers | Leave a comment